Four microreactor developers have achieved zero-power fuelled criticality under U.S. federal programs to fast-track advanced ...
– Multi-target collaboration will leverage Antares’ proprietary discovery engine to generate highly selective small molecule medicines against historically undruggable oncology targets – – Antares to ...
Novartis is paying $105 million upfront to task Antares Therapeutics with generating small molecules against historically undruggable oncology targets. Antares spun out of Scorpion Therapeutics in ...
June 24 (Reuters) - Antares Therapeutics said on Wednesday it entered a collaboration with Novartis (NOVN.S), opens new tab that could be worth up to about $1.9 billion, aiming to develop therapies ...
A $105 million upfront payment supports joint discovery of first-in-class precision medicines, with potential milestones totaling $1.8 billion linked to development, regulatory, and commercial ...
XREAL continues to pioneer the smart glasses form factor, and with power from Asus display hardware, the ROG R1 is born. The XREAL ROG R1 glasses make a solid companion for mobile gaming and, to an ...
What is the current share price of Antares Metals Limited (AM5)? Antares Metals Limited's (AM5) current share price is $0.01. This constitutes a price movement of 8.33% when compared to the share ...
In early 2025 UW achieved Research Level 1 (R1) status from the Carnegie Classification of Institutions of Higher Education, placing Wyoming's only four-year university with the top research ...
Novartis and Antares Therapeutics are shooting for the stars, launching a joint mission to develop small molecule oncology therapies. Novartis is paying $105 million cash and offering Antares up to $1 ...
Agent-R1 is a unified, modular framework for Agentic Reinforcement Learning. It trains multi-step LLM agents through a step-native RL loop, where the model observes an environment, generates an action ...
Novartis has spent the last three years — and billions of dollars — loading its pipeline with cancer drug prospects. Among those investments were its acquisitions of MorphoSys and Mariana Oncology in ...
Although chain-of-thought (CoT) reasoning and reinforcement learning (RL) have driven breakthroughs in NLP, their integration into generative vision models remains underexplored. We introduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results